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Abstract
Objectives: There are unique challenges to enrolling patients in emergency department (ED) clinical
research studies, including the time-sensitive nature of emergency conditions, the acute care environ-
ment, and the lack of an established relationship with patients. Prolonged ED wait times have been asso-
ciated with a variety of adverse effects on patient care. The objective of this study was to assess the
effect of ED wait times on patient participation in ED clinical research. The hypothesis was that
increased ED wait times would be associated with reduced ED clinical research consent rates.
Methods: This was a retrospective cohort study of all patients eligible for two diagnostic clinical research
studies from January 1, 2008, through December 31, 2008, in an urban academic ED. Sex, age, race, study
eligibility, and research consent decisions were recorded by trained study personnel. The wait times to
registration and to be seen by a physician were obtained from administrative databases and compared
between consenters and nonconsenters. An analysis of association between patient wait times for the
outcome of consent to participate was performed using a multivariate logistic regression model.
Results: A total of 903 patients were eligible for enrollment and were asked for consent. Overall, 589
eligible patients (65%) gave consent to research participation. The consent rates did not change when
patients were stratified by the highest and lowest quartile wait times for both time from arrival to regis-
tration (68% vs. 65%, p = 0.35) and time to be seen by a physician (65% vs. 66%, p = 0.58). After adjusting
for patient demographics (age, race, and sex) and study, there was still no relationship between wait
times and consent (p > 0.4 for both wait times). Furthermore, median time from arrival to registration did
not differ between those who consented to participate (15 minutes; interquartile range [IQR] = 9 to
36 minutes) versus those who did not (15.5 minutes; IQR = 10 to 39 minutes; p = 0.80; odds ratio
[OR] = 1.00, 95% confidence interval [CI] = 0.99 to 1.01). Similarly, there was no difference in the median
time to be seen by a physician between those who consented (25 minutes; IQR = 15 to 55 minutes) versus
those who did not (25 minutes; IQR = 15 to 56 minutes; p = 0.70; OR = 1.00, 95% CI = 0.99 to 1.01).
Conclusions: Regardless of wait times, nearly two-thirds of eligible patients were willing to consent to
diagnostic research studies in the ED. These findings suggest that effective enrollment in clinical
research is possible in the ED, despite challenges with prolonged wait times.
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T
he 2006 Institute of Medicine report on emer-
gency care called for increased research efforts
to enhance emergency medical care.1 One
challenging aspect of emergency medicine (EM) research
is the informed consent process. Participation in EM
research studies is influenced by a wide variety of
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factors, including characteristics of the patients, the
study specifics, and the setting.2,3 Identifying and
addressing barriers to informed consent is critical, as
populations frequently seen in emergency departments
(EDs) are underrepresented in other research settings.
Although many studies have investigated which
patient features are associated with willingness to par-
ticipate in research, most of these have been in fields
other than EM.4–10 Those in the field of EM have exam-
ined features of the patient or informed consent docu-
ment associated with research participation.2,3,11–15 It is
not clear how the clinical care provided to the patient
affects his or her decision to participate in research. It
has been demonstrated that wait times can affect a
patient’s overall satisfaction with an ED visit.16,17 It has
also been shown in a hypothetical research setting that
patients value convenience when deciding on research
participation.18 Additionally, many subjects participate
in research out of a sense of altruism,19 which might be
reduced if a patient is dissatisfied with his or her over-
all ED visit. Therefore, prolonged ED wait times might
adversely affect EM research participation. To the
best of our knowledge, this possibility has not been
examined.
The objective of this study was to determine the
effect of ED wait times on patient participation in EM
research. We hypothesized that increased ED wait
times would be associated with reduced research con-
sent rates for two diagnostic ‘‘parent’’ research studies.
METHODS
Study Design
This was a retrospective observational study of the rela-
tionship between ED wait times and research participa-
tion. This study was submitted to and exempted from
full review and informed consent requirements by our
institutional review board (IRB).
Study Setting and Population
Subjects included patients screened for enrollment into
two EM minimal-risk diagnostic research studies that
were funded by the National Institutes of Health from
the period of January 2008 through December 2008 at
an urban academic medical center ED with an average
annual census of approximately 65,000 visits. During
the time period of the current study, the median wait
times to be registered, to be seen by a physician, and
overall length of stay were 18, 27, and 301 minutes,
respectively, for patients seen in this ED.
Both parent studies were approved by our institu-
tional review board. Trained study coordinators
screened for eligible patients with infection from 8 AM
to 10 PM during weekdays, with intermittent sampling
on weekends. Eligible patients were approached for the
parent studies as soon as possible after being evaluated
by an attending emergency physician in a treatment
room. Patients were eligible for either of the two parent
research studies if they had a suspected infection and
two or more systemic inflammatory response signs
(Study 1) or had signs and symptoms of pneumonia as
determined by emergency physician evaluation (Study
2). They were excluded from the parent studies if they
could not speak English or were not competent to con-
sent. After patient consent was obtained, research
coordinators obtained blood samples, using existing
intravenous lines whenever possible. The only other
intervention for either parent study was data collection
and follow-up. Neither study required a time-sensitive
window for enrollment.
Study Protocol
For each eligible patient, pertinent wait times were
obtained from administrative databases. Trained study
personnel recorded patient sex, age, race, study eligibil-
ity, and consent. Study personnel kept prospective
screening logs, including demographics and reasons
for nonenrollment for all eligible patients. All study per-
sonnel completed both local IRB-mandated general
training and parent study protocol-specific research
training.
We collected the following wait times: 1) time from
patient arrival (when a patient is first entered into the
electronic tracking board) to full registration and tri-
age (as defined as the time of first nursing triage
note) and 2) time from arrival to being seen by a phy-
sician (as noted by a physician ‘‘signing up’’ for the
patient on electronic tracking board). Consent to par-
ticipate was considered our binary outcome. Overall
ED length of stay times were recorded for descriptive
purposes.
Data Analysis
Demographic data are reported as proportions. All
patient wait time data are presented in minutes and as
medians with interquartile ranges (IQR). We performed
a chi-square test comparing the underlying characteris-
tics of consenting and nonconsenting patientsm to
determine if consent rates were associated with age,
race, or sex. As wait times were not normally distrib-
uted, the Wilcoxon rank sum test was used. Addition-
ally, a Cochran-Armitage test for trend to compare
participation rates across wait time quartiles was
performed.
We then analyzed the association between consent
rates and patient wait times using a multivariate logistic
regression model. Because our sample was derived
from two parent studies, we knew a priori how many
subjects had consented and were thus confident of hav-
ing enough events to power our analysis. However, we
used 1 year’s worth of data to account for any seasonal
variation. Two separate models were built. Time to reg-
istration and time to see a physician were entered into
separate models to avoid colinearity. Both models con-
tained patient demographics (age, race, sex) and parent
study for which the patient was approached as main
effect predictor variables. These predictor variables
were selected based on prior research performed at
this site and the general literature on this topic.3–6,9,20–29
In both models, we identified consent to participate
as our outcome variable. Overall robustness of the
models was determined by )2 log likelihood statistic. A
p-value £ 0.05 was considered statistically significant,
with no adjustment for multiple comparisons. All
analyses were performed using SAS (Version 9.2, SAS
Institute, Cary, NC).

































































Overall, 1403 patients were approached for these
research studies, of whom 36% were ineligible, leaving
903 patients eligible for participation. Of these patients,
589 patients (65%) consented to participate and were
enrolled. Patient demographics are listed in Table 1. In
univariate analysis, demographics were not significantly
different between those consenting to participate and
those not consenting (Table 1).
Overall, the median time from arrival to registration
was 15 minutes (IQR = 9 to 37 minutes), arrival to being
seen by a physician was 26 minutes (IQR = 15 to
57 minutes), and length of stay was 505 minutes
(IQR = 351 to 705.5 minutes). The median time from
arrival to registration was similar (p = 0.8) between the
consent group (15 minutes; IQR = 9 to 36 minutes) and
nonconsent group (15.5 minutes; IQR = 10 to 39 min-
utes). Furthermore, median times from arrival to being
seen by a physician were similar (p = 0.7) between the
consent group (25 minutes; IQR = 15 to 55 minutes) and
nonconsent group (25 minutes; IQR = 15 to 56 minutes).
Likewise, the percentage of patients consenting to
participation was compared across wait time quartiles
for arrival to registration and arrival to being seen by a
physician (Figure 1). Percent consented was not differ-
ent between the highest and lowest wait time quartiles
(p = 0.35 for time to registration, p = 0.58 for time to
being seen).
After adjustment for potential confounders, consent
was not associated with time to registration or time to
be seen. Only the parent study for which patients were
approached showed any significant association with
consent (Tables 2 and 3).
DISCUSSION
In this study, we analyzed the relationship between
ED wait times and EM research participation. After
adjusting for patient demographics, we found that the
majority of eligible patients consented to the two diag-
nostic research studies regardless of wait times. To our
knowledge, this is the first study examining the effects
of wait times on ED clinical research participation. Pre-
vious work has examined various factors that influence
research participation including age, sex, education,
geographical residence, race ⁄ethnicity, income, famil-
iarity with clinical trials, trust of the medical system,
disease severity, availability of surrogate decision-
makers, health beliefs, readability of consent docu-
ments, and qualifications of the research staff
approaching subjects.3–6,13,14,20,22,23,25–27,29–35
This study’s findings highlight the complex nature
of EM research consent. Altruism has been identified
as a key factor in research participation.19 Inconve-
nienced patients may feel less altruistic.18 We there-
fore hypothesized that patients who are forced to wait
longer to register or to see a physician would be less
willing to enroll in a research study, especially for
studies that do not provide financial compensation or
direct clinical benefit. Our findings indicate that other
factors play a more important role in the decision to
participate in research. Patients demonstrated a high
rate of willingness to participate in research studies.
Although it is not clear whether these observations
will hold for non-ED settings, our findings are encour-
aging for ED research sites with prolonged wait
times.
Also of note, in the current study we found no differ-
ence in enrollment in different racial or age groups.
This is in contrast to prior work performed at this same
site.3 Although the reasons for this are unclear, possible
reasons include staff awareness of the prior publication
and increased sensitivity to enrolling patients who were
previously underrepresented. Other possibilities are
turnover in research staff and differences in the parent
research studies from which this sample was drawn.
Although not the focus of the current study, this find-
ing is encouraging, suggesting that racial and age
disparities in research participation can be ameliorated.
Table 1
Total Demographics and Wait Times and Univariate Comparison by Consent Outcome
Characteristics Total (N = 903) Consenters (n = 589) Nonconsenters (n = 314) p-value
Age (yr)
Younger than 18 44 (4.8%) 28 (4.8%) 16 (5.1%) 0.2
18–40 235 (26.0%) 156 (26.5%) 79 (25.2%)
41–65 384 (42.5%) 261 (44.3%) 123 (39.2%)
Older than 65 240 (26.6%) 144 (24.4%) 96 (30.6%)
Race
Black or African American 394 (43.6%) 256 (43.5%) 138 (43.9%) 1.0
White 470 (52.0%) 307 (52.1%) 163 (51.9%)
Other 39 (4.3%) 26 (4.4%) 13 (4.1%)
Sex
Male 426 (47.2%) 282 (47.9%) 144 (45.9%) 0.6
Time to registration, minutes (IQR) 15 (9–37) 15 (9–36) 15.5 (10–39) 0.8
Time to be seen by physician, minutes (IQR) 26 (15–57) 25 (15–55) 25 (15–56) 0.7
Time to registration = time from patient arrival (when a patient presented to the front desk or arrived by ambulance) to full reg-
istration and triage; time to be seen by a physician = time from arrival to being seen (as noted by a physician ‘‘signing up’’ for
the patient on electronic tracking board).
Univariate comparisons were made between consenters versus nonconsenters with the chi-square test with p-values as
reported. No adjustments were made for multiple comparisons.
IQR = interquartile range.

































































This study is limited by use of administrative data for
measures of ED crowding. These are created on the
basis of time stamps created by our electronic charting
system, and as such are subject to inaccuracies caused
by idiosyncratic use of the charting system by pro-
viders. Overall, however, because our subjects were
(a)
(b)
Figure 1. 3Xxxxxxxxxxxxxxxxxx. 1
Table 2
Multivariate Logistic Regression Analysis for Time to
Registration
Variables Coefficient OR 95% CI p-value
Age )0.005 0.99 (0.99–1.00) 0.14
Sex (male) 0.076 1.08 (0.81–1.43) 0.60
Race (white) 0.081 1.09 (0.80–1.47) 0.59
Parent study
(pneumonia)




)0.0001 1.00 (0.998–1.001) 0.89
Parent study = the parent study for which patient was
approached; time to registration = time from patient arrival
(when a patient presented to the front desk or arrived by
ambulance) to full registration and triage.
Robustness of model was assessed by )2 log L = 1109.8.
Table 3
Multivariate Logistic Regression Analysis for Time to Physician 2
Variables Coefficient OR 95% CI p-value
Age )0.005 1.00 (0.99–1.00) 0.17
Sex (male) 0.068 1.07 (0.80–1.43) 0.64
Race (white) 0.026 1.03 (0.76–1.39) 0.86
Parent study
(pneumonia)




)0.0002 1.00 (0.998–1.001) 0.78
Parent study = the parent study for which patient was
approached; time to physician = time from arrival to being
seen (as noted by a physician ‘‘signing up’’ for the patient on
electronic tracking board).













































































randomly distributed across providers, this should not
produce a systematic bias to this study. Our study does
not address the time from arrival until patients are
approached for consent. The patients in this study were
approached as soon as possible after physician evalua-
tion. Although we did not systematically record the
time of approach, this time was usually within 2 hours
of physician evaluation. We hypothesized that patients’
participation decisions would be affected by their wait
for medical care, not how long they had been in the ED
prior to being approached for consent. Whether the lat-
ter is more important is a separate research question
worthy of further study.
There are multiple other potential confounders that
we were not able to control. This study also does not
control for patient perceptions and attitudes toward
research. It is possible that patients with longer waits
were either more or less inclined toward research at
baseline. Patients with longer wait times will also be
systematically biased toward having lower acuity of
illness by nature of triage protocols. It is possible that
severity of illness affects patient willingness to partici-
pate in research trials. Another possible confounder
not controlled for was the characteristics of the
research staff approaching patients. Our findings are
restricted to research studies without time-sensitive
windows to enrollment. Such studies may affect non-
participation by increasing time pressures on research
staff. There is no literature to support any of these as
confounders in EM research, but future study could
evaluate their effect on participation.
CONCLUSIONS
We found that patient wait times did not adversely
affect ED research participation. We believe that our
results show that patients can be recruited for research
even in clinical environments where patients are
required to wait for care. Future efforts should focus
on elucidating factors associated with research partici-
pation and refusal and the effect of crowding on time-
sensitive research and on vulnerable populations such
as those who are unable to consent, critically ill
patients, and populations underrepresented in other
research settings.
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